Prognostic role of diffusion weighted and dynamic contrast-enhanced MRI in loco-regionally advanced head and neck cancer treated with concomitant chemoradiotherapy

1Ferlay J, Soerjomataram I, Dikshit R, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. doi: 10.1002/ijc.29210 Ferlay J Soerjomataram I Dikshit R Parkin DM Forman D Bray F Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 2015 136 E35986 10.1002/ijc.29210Open DOISearch in Google Scholar

2Strojan P. [New approaches to radiotherapy of head and neck tumors]. [Slovenian]. Zdr Vestn 2010; 79: 339-53. Strojan P [New approaches to radiotherapy of head and neck tumors]. [Slovenian] Zdr Vestn 2010 79 33953Search in Google Scholar

3Winquist E, Agbassi C, Meyers BM, Yoo J, Chan KKW. Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review. J Otolaryngol Head Neck Surg 2017; 46: 29. doi: 10.1186/s40463-017-0199-x Winquist E Agbassi C Meyers BM Yoo J Chan KKW Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review J Otolaryngol Head Neck Surg 2017 46 29 10.1186/s40463-017-0199-xOpen DOISearch in Google Scholar

4Leeman JE, Li J, Pei X, Venigalla P, Zumsteg ZS, Katsoulakis E, et al. Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques. JAMA Oncol 2017; 3: 1487-94. doi: 10.1001/jamaoncol.2017.0973 Leeman JE Li J Pei X Venigalla P Zumsteg ZS Katsoulakis E Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques JAMA Oncol 2017 3 148794 10.1001/jamaoncol.2017.0973Open DOISearch in Google Scholar

5Pignon J-P, Maître A le, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14. doi: 10.1016/j. radonc.2009.04.014 Pignon J-P Maître A le Maillard E Bourhis J Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 2009 92 414 10.1016/j radonc.2009.04.014Open DOISearch in Google Scholar

6Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol 2004; 58: 141823. doi: 10.1016/j.ijrobp.2003.09.004 Brizel DM Prosnitz RG Hunter S Fisher SR Clough RL Downey MA Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer Int J Radiat Oncol 2004 58 141823 10.1016/j.ijrobp.2003.09.004Open DOISearch in Google Scholar

7Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al; MACH-CH Collaborative group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 2011; 100: 33-40. doi: 10.1016/j.radonc.2011.05.036 Blanchard P Baujat B Holostenco V Bourredjem A Baey C Bourhis J MACH-CH Collaborative group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site Radiother Oncol 2011 100 3340 10.1016/j.radonc.2011.05.036Open DOISearch in Google Scholar

8Bisdas S, Rumboldt Z, Surlan-Popovic K, Baghi M, Koh TS, Vogl TJ, et al. Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. AJNR Am J Neuroradiol 2010; 31: 576-81. doi: 10.3174/ajnr.A1852 Bisdas S Rumboldt Z Surlan-Popovic K Baghi M Koh TS Vogl TJ Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements AJNR Am J Neuroradiol 2010 31 57681 10.3174/ajnr.A1852Open DOISearch in Google Scholar

9Surlan-Popovic, K. Bisdas S, Rumboldt Z, Koh TS, Strojan P. Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. Am J Neuroradiol 2010; 31: 570-5. doi: 10.3174/ajnr.A1859 Surlan-Popovic K. Bisdas S Rumboldt Z Koh TS Strojan P Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy Am J Neuroradiol 2010 31 5705 10.3174/ajnr.A1859Open DOISearch in Google Scholar

10Pietsch C, de Galiza Barbosa F, Hullner MW, Schmid DT, Haerle SK, Huber GF, et al. Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study. BMC Med Imaging 2015; 15: 60. doi: 10.1186/s12880-015-0102-z Pietsch C de Galiza Barbosa F Hullner MW Schmid DT Haerle SK Huber GF Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study BMC Med Imaging 2015 15 60 10.1186/s12880-015-0102-zOpen DOISearch in Google Scholar

11Koh D-M, Lee J-M, Bittencourt LK, Blackledge M, Collins DJ. Body diffusion-weighted MR imaging in oncology. Magn Reson Imaging Clin N Am 2016; 24: 31-44. doi: 10.1016/j.mric.2015.08.007 Koh D-M Lee J-M Bittencourt LK Blackledge M Collins DJ Body diffusion-weighted MR imaging in oncology Magn Reson Imaging Clin N Am 2016 24 3144 10.1016/j.mric.2015.08.007Open DOISearch in Google Scholar

12Gaddikeri S, Gaddikeri RS, Tailor T, Anzai Y. Dynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applications. AJNR Am J Neuroradiol 2016; 37: 588-95. doi: 10.3174/ajnr.A4458 Gaddikeri S Gaddikeri RS Tailor T Anzai Y Dynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applications AJNR Am J Neuroradiol 2016 37 58895 10.3174/ajnr.A4458Open DOISearch in Google Scholar

13Kim H, Hartman YE, Zhai G, Chung TK, Korb ML, Beasley TM, et al. Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation. J Magn Reson Imaging 2015; 42: 936-45. doi: 10.1002/jmri.24871 Kim H Hartman YE Zhai G Chung TK Korb ML Beasley TM Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation J Magn Reson Imaging 2015 42 93645 10.1002/jmri.24871Open DOISearch in Google Scholar

14Cao Y, Popovtzer A, Li D, Chepeha DB, Moyer JS, Prince ME, et al. Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys 2008; 72: 1287-90. doi: 10.1016/j.ijrobp.2008.08.024.EARLY Cao Y Popovtzer A Li D Chepeha DB Moyer JS Prince ME Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study Int J Radiat Oncol Biol Phys 2008 72 128790 10.1016/j.ijrobp.2008.08.024.EARLYOpen DOISearch in Google Scholar

15Baer AH, Hoff BA, Srinivasan A, Galbán CJ, and Mukherji SK. Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer. AJNR Am J Neuroradiol 2015; 36: 757-62. doi: 10.3174/ajnr.A4296 Baer AH Hoff BA Srinivasan A Galbán CJ Mukherji SK Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer AJNR Am J Neuroradiol 2015 36 75762 10.3174/ajnr.A4296Open DOISearch in Google Scholar

16Strojan P, Zadnik V, Šifrer R, Lanišnik B, Didanović V, Jereb S, et al. Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983–2009: role of human papillomavirus infection. Eur Arch Otorhinolaryngol 2015; 272: 3805-14. doi: 10.1007/s00405-014-3459-7 Strojan P Zadnik V Šifrer R Lanišnik B Didanović V Jereb S Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983–2009: role of human papillomavirus infection Eur Arch Otorhinolaryngol 2015 272 380514 10.1007/s00405-014-3459-7Open DOISearch in Google Scholar

17Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-32. doi: 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S Tofts PS Brix G Buckley DL Evelhoch JL Henderson E Knopp MV Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols J Magn Reson Imaging 1999 10 22332 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-SOpen DOISearch in Google Scholar

18Schwartz DL, Garden AS, Thomas J, Chen Y, Zhang Y, Lewin J, et al. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys 2012; 83: 986-93. doi: 10.1016/j. ijrobp.2011.08.017 Schwartz DL Garden AS Thomas J Chen Y Zhang Y Lewin J Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial Int J Radiat Oncol Biol Phys 2012 83 98693 10.1016/j ijrobp.2011.08.017Open DOISearch in Google Scholar

19Yuan J, Lo G, King AD. Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers. Quant Imaging Med Surg 2016; 6: 430-48. doi: 10.21037/qims.2016.06.11 Yuan J Lo G King AD Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers Quant Imaging Med Surg 2016 6 43048 10.21037/qims.2016.06.11Open DOISearch in Google Scholar

20Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, et al. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2010; 31: 262-8. doi: 10.3174/ajnr.A1817 Kim S Loevner LA Quon H Kilger A Sherman E Weinstein G Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging AJNR Am J Neuroradiol 2010 31 2628 10.3174/ajnr.A1817Open DOISearch in Google Scholar

21Chawla S, Kim S, Loevner LA, Hwang WT, Weinstein G, Chalian A, et al. Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011; 32: 778-84. doi: 10.3174/ajnr.A2376 Chawla S Kim S Loevner LA Hwang WT Weinstein G Chalian A Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging AJNR Am J Neuroradiol 2011 32 77884 10.3174/ajnr.A2376Open DOISearch in Google Scholar

22Chawla S, Kim S, Dougherty L, Wang S, Loevner LA, Quon H, et al. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. Am J Roentgenol 2013; 200: 35-43. doi: 10.2214/AJR.12.9432 Chawla S Kim S Dougherty L Wang S Loevner LA Quon H Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck Am J Roentgenol 2013 200 3543 10.2214/AJR.12.9432Open DOISearch in Google Scholar

23Chikui T, Kitamoto E, Kawano S, Sugiura T, Obara M, Simonetti AW, et al. Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer. J Magn Reson Imaging 2012; 36: 589-97. doi: 10.1002/jmri.23704 Chikui T Kitamoto E Kawano S Sugiura T Obara M Simonetti AW Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer J Magn Reson Imaging 2012 36 58997 10.1002/jmri.23704Open DOISearch in Google Scholar

24Ng SH, Lin CY, Chan SC, Yen TC, Liao CT, Chang JT, et al. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. PLoS One 2013; 8: 1-11. doi: 10.1371/journal.pone.0072230 Ng SH Lin CY Chan SC Yen TC Liao CT Chang JT Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy PLoS One 2013 8 111 10.1371/journal.pone.0072230Open DOISearch in Google Scholar

25Ng SH, Lin CY, Chan SC, Lin YC, Yen TC, Liao CT, et al. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and18F-FDG PET/ CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. PLoS One 2014; 9: 1-19. doi: 10.1371/journal.pone.0115933 Ng SH Lin CY Chan SC Lin YC Yen TC Liao CT Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and18F-FDG PET/ CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation PLoS One 2014 9 119 10.1371/journal.pone.0115933Open DOISearch in Google Scholar

26Chan SC, Cheng NM, Hsieh CH, et al. Multiparametric imaging using ¹⁸F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 2017; 8: 62606-21. doi: 10.18632/oncotarget.15904 Chan SC Cheng NM Hsieh CH Multiparametric imaging using ¹⁸F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy Oncotarget 2017 8 6260621 10.18632/oncotarget.15904Open DOISearch in Google Scholar

27Surov A, Meyer HJ, Leifels L, Höhn A-K, Richter C, Winter K. Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma. Oncotarget 2018; 9: 21070-7. doi: 10.18632/oncotarget.24920 Surov A Meyer HJ Leifels L Höhn A-K Richter C Winter K Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma Oncotarget 2018 9 210707 10.18632/oncotarget.24920Open DOISearch in Google Scholar

28Kim SH, Lee HS, Kang BJ, Song BJ, Kim HB, Lee H, et al. Dynamic contrast-enhanced MRI perfusion parameters as imaging biomarkers of angiogenesis. PLoS One 2016; 11: 1-12. doi: 10.1371/journal.pone.0168632 Kim SH Lee HS Kang BJ Song BJ Kim HB Lee H Dynamic contrast-enhanced MRI perfusion parameters as imaging biomarkers of angiogenesis PLoS One 2016 11 112 10.1371/journal.pone.0168632Open DOISearch in Google Scholar

29Choi YJ, Lee JH, Kim HO, Kim DY, Yoon RG, Cho SH, et al. Histogram analysis of apparent diffusion coefficients for occult tonsil cancer in patients with cervical nodal metastasis from an unknown primary site at presentation. Radiology 2016; 278: 146-55. doi: 10.1148/radiol.2015141727 Choi YJ Lee JH Kim HO Kim DY Yoon RG Cho SH Histogram analysis of apparent diffusion coefficients for occult tonsil cancer in patients with cervical nodal metastasis from an unknown primary site at presentation Radiology 2016 278 14655 10.1148/radiol.2015141727Open DOISearch in Google Scholar

30García-Figueiras R, Padhani AR, Beer AJ, Baleato-González S, Vilanova JC, Luna A, et al. Imaging of tumor angiogenesis for radiologists - part 1: biological and technical basis. Curr Probl Diagn Radiol 2015; 44: 407-24. doi: 10.1067/j.cpradiol.2015.02.010 García-Figueiras R Padhani AR Beer AJ Baleato-González S Vilanova JC Luna A Imaging of tumor angiogenesis for radiologists - part 1: biological and technical basis Curr Probl Diagn Radiol 2015 44 40724 10.1067/j.cpradiol.2015.02.010Open DOISearch in Google Scholar

31Manoochehri Khoshinani H, Afshar S, Najafi R. Hypoxia: a double-edged sword in cancer therapy. Cancer Invest 2016; 34: 536-45. doi: 10.1080/07357907.2016.1245317 Manoochehri Khoshinani H Afshar S Najafi R Hypoxia: a double-edged sword in cancer therapy Cancer Invest 2016 34 53645 10.1080/07357907.2016.1245317Open DOISearch in Google Scholar

32Ng SH, Liao CT, Lin CY, Chan SC, Lin YC, Yen TC, et al. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and ¹⁸F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treatedwithchemoradiation. Eur Radiol 2016; 26: 4162-72. doi: 10.1007/s00330-016-4276-8 Ng SH Liao CT Lin CY Chan SC Lin YC Yen TC Dynamic contrast-enhanced MRI, diffusion-weighted MRI and ¹⁸F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treatedwithchemoradiation Eur Radiol 2016 26 416272 10.1007/s00330-016-4276-8Open DOISearch in Google Scholar

33Preda L, Conte G, Bonello L, Giannitto C, Travaini LL, Raimondi S, et al. Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma. Eur Radiol 2016; 26: 4432-41. doi: 10.1007/s00330-016-4284-8 Preda L Conte G Bonello L Giannitto C Travaini LL Raimondi S Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma Eur Radiol 2016 26 443241 10.1007/s00330-016-4284-8Open DOISearch in Google Scholar

34Noij DP, de Jong MC, Mulders LG, Marcus JT, de Bree R, Lavini C, et al. Contrast-enhanced perfusion magnetic resonance imaging for head and neck squamous cell carcinoma: a systematic review. Oral Oncol 2015; 51: 124-38. doi: 10.1016/j.oraloncology.2014.10.016 Noij DP de Jong MC Mulders LG Marcus JT de Bree R Lavini C Contrast-enhanced perfusion magnetic resonance imaging for head and neck squamous cell carcinoma: a systematic review Oral Oncol 2015 51 12438 10.1016/j.oraloncology.2014.10.016Open DOISearch in Google Scholar

35Driessen JP, Caldas-Magalhaes J, Janssen LM, et al. Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. Radiology 2014; 272: 456-63. doi: 10.1148/radiol.14131173 Driessen JP Caldas-Magalhaes J Janssen LM Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings Radiology 2014 272 45663 10.1148/radiol.14131173Open DOISearch in Google Scholar

36Kolenda T, Przybyła W, Kapałczyńska M, Teresiak A, Zajączkowska M, Bliźniak R, et al. Tumor microenvironment - unknown niche with powerful therapeutic potential. Rep Pract Oncol Radiother 2018; 23: 143-53. doi: 10.1016/j. rpor.2018.01.004 Kolenda T Przybyła W Kapałczyńska M Teresiak A Zajączkowska M Bliźniak R Tumor microenvironment - unknown niche with powerful therapeutic potential Rep Pract Oncol Radiother 2018 23 14353 10.1016/j rpor.2018.01.004Open DOISearch in Google Scholar

37Choi HS, Kim AH, Ahn SS, Shin NY, Kim J, Lee SK. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI. Korean J Radiol 2013; 14: 487-92. doi: 10.3348/kjr.2013.14.3.487 Choi HS Kim AH Ahn SS Shin NY Kim J Lee SK Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI Korean J Radiol 2013 14 48792 10.3348/kjr.2013.14.3.487Open DOISearch in Google Scholar

38Rata M, Collins DJ, Darcy J, Messiou C, Tunariu N, Desouza N, et al. Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions. Eur Radiol 2016; 26: 1991-1998. doi: 10.1007/s00330-015-4012-9 Rata M Collins DJ Darcy J Messiou C Tunariu N Desouza N Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions Eur Radiol 2016 26 19911998 10.1007/s00330-015-4012-9Open DOISearch in Google Scholar